vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Intellicheck, Inc. (IDN). Click either name above to swap in a different company.
Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $6.6M, roughly 1.2× Intellicheck, Inc.). Intellicheck, Inc. runs the higher net margin — 23.4% vs -766.0%, a 789.4% gap on every dollar of revenue. On growth, Intellicheck, Inc. posted the faster year-over-year revenue change (11.8% vs -79.3%). Intellicheck, Inc. produced more free cash flow last quarter ($2.4M vs $-63.9M). Over the past eight quarters, Intellicheck, Inc.'s revenue compounded faster (19.1% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
Intellicheck, Inc. is a US-based technology company specializing in identity verification and fraud prevention solutions. It develops AI-powered tools to validate government-issued identification documents, streamline customer onboarding, and mitigate identity theft risks for clients across finance, retail, healthcare and public sector segments.
ACLX vs IDN — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $6.6M |
| Net Profit | $-62.3M | $1.6M |
| Gross Margin | — | 91.4% |
| Operating Margin | -847.6% | 22.5% |
| Net Margin | -766.0% | 23.4% |
| Revenue YoY | -79.3% | 11.8% |
| Net Profit YoY | -765.1% | 218.0% |
| EPS (diluted) | $-1.13 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $6.0M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | $8.1M | $4.9M | ||
| Q4 24 | $15.3M | $5.9M | ||
| Q3 24 | $26.0M | $4.7M | ||
| Q2 24 | $27.4M | $4.7M | ||
| Q1 24 | $39.3M | $4.7M |
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $290.0K | ||
| Q2 25 | — | $-251.0K | ||
| Q1 25 | $-62.3M | $-318.0K | ||
| Q4 24 | $-47.1M | $488.0K | ||
| Q3 24 | $-25.9M | $-837.0K | ||
| Q2 24 | $-27.2M | $-127.0K | ||
| Q1 24 | $-7.2M | $-442.0K |
| Q4 25 | — | 91.4% | ||
| Q3 25 | — | 90.5% | ||
| Q2 25 | — | 89.8% | ||
| Q1 25 | — | 89.7% | ||
| Q4 24 | — | 91.1% | ||
| Q3 24 | — | 91.0% | ||
| Q2 24 | — | 90.5% | ||
| Q1 24 | — | 90.7% |
| Q4 25 | — | 22.5% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | -5.8% | ||
| Q1 25 | -847.6% | -7.1% | ||
| Q4 24 | -348.2% | 8.1% | ||
| Q3 24 | -129.1% | -19.3% | ||
| Q2 24 | -127.8% | -4.6% | ||
| Q1 24 | -40.3% | -11.2% |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | -766.0% | -6.5% | ||
| Q4 24 | -308.4% | 8.2% | ||
| Q3 24 | -99.4% | -17.8% | ||
| Q2 24 | -99.3% | -2.7% | ||
| Q1 24 | -18.3% | -9.4% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | $-1.13 | $-0.02 | ||
| Q4 24 | $-0.87 | $0.02 | ||
| Q3 24 | $-0.48 | $-0.04 | ||
| Q2 24 | $-0.51 | $-0.01 | ||
| Q1 24 | $-0.14 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $9.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $20.7M |
| Total Assets | $648.1M | $24.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $7.2M | ||
| Q2 25 | — | $8.6M | ||
| Q1 25 | $543.3M | $5.1M | ||
| Q4 24 | $587.4M | $4.7M | ||
| Q3 24 | $574.3M | $5.7M | ||
| Q2 24 | $516.7M | $7.3M | ||
| Q1 24 | $573.9M | $9.2M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | $416.9M | $17.6M | ||
| Q4 24 | $454.8M | $17.7M | ||
| Q3 24 | $483.0M | $16.7M | ||
| Q2 24 | $487.2M | $17.3M | ||
| Q1 24 | $496.6M | $17.2M |
| Q4 25 | — | $24.5M | ||
| Q3 25 | — | $25.3M | ||
| Q2 25 | — | $23.1M | ||
| Q1 25 | $648.1M | $24.6M | ||
| Q4 24 | $711.3M | $20.9M | ||
| Q3 24 | $764.9M | $20.7M | ||
| Q2 24 | $734.3M | $21.9M | ||
| Q1 24 | $779.7M | $22.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $2.4M |
| Free Cash FlowOCF − Capex | $-63.9M | $2.4M |
| FCF MarginFCF / Revenue | -786.4% | 36.0% |
| Capex IntensityCapex / Revenue | 9.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.54× |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-1.7M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | $-63.1M | $750.0K | ||
| Q4 24 | $-46.0M | $-1.3M | ||
| Q3 24 | $30.7M | $-1.1M | ||
| Q2 24 | $-36.2M | $-1.2M | ||
| Q1 24 | $-31.9M | $869.0K |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | $-63.9M | $741.0K | ||
| Q4 24 | $-47.5M | $-1.3M | ||
| Q3 24 | $28.4M | $-1.1M | ||
| Q2 24 | $-39.5M | $-1.2M | ||
| Q1 24 | $-38.3M | $860.0K |
| Q4 25 | — | 36.0% | ||
| Q3 25 | — | -29.2% | ||
| Q2 25 | — | 60.9% | ||
| Q1 25 | -786.4% | 15.1% | ||
| Q4 24 | -311.3% | -22.4% | ||
| Q3 24 | 109.2% | -23.1% | ||
| Q2 24 | -144.1% | -25.5% | ||
| Q1 24 | -97.7% | 18.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 9.6% | 0.2% | ||
| Q4 24 | 9.8% | 0.2% | ||
| Q3 24 | 8.8% | 0.6% | ||
| Q2 24 | 11.7% | 0.2% | ||
| Q1 24 | 16.4% | 0.2% |
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | -5.99× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.71× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
